Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The progesterone receptor Val660-->Leu polymorphism and breast cancer risk.

Breast cancer research : BCR - 1 Jan 2004

De Vivo Immaculata, Hankinson Susan E, Colditz Graham A, Hunter David J

Abstract excerpt

BACKGROUND: Recent evidence suggests a role for progesterone in breast cancer development and tumorigenesis. Progesterone exerts its effect on target cells by interacting with its receptor; thus, genetic variations, which might cause alterations in the biological function in the progesterone receptor (PGR), can potentially contribute to an individual's susceptibility to breast cancer. It has been reported that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies
Share to Leucine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Postmenopause

Share to Premenopause

Share to Receptors, Progesterone

Share to Valine

Source

Open in PubMed Open full text

Identifiers

PMID: 15535845
DOI: 10.1186/bcr928
PMCID: PMC1064075

Genes

PGR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The progesterone receptor Val660-->Leu polymorphism and breast cancer risk.PMID 15535845Read ↗

Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.Semantic proximity Read ↗

Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk.Semantic proximity Read ↗

Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.Semantic proximity Read ↗

Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.Semantic proximity Read ↗

The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.Semantic proximity Read ↗

Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.Semantic proximity Read ↗

Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia.Semantic proximity Read ↗

Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.Semantic proximity Read ↗

A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.Semantic proximity Read ↗

Genetic variation in the progesterone receptor gene and ovarian cancer risk.Semantic proximity Read ↗

Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.Semantic proximity Read ↗

Progesterone receptor gene variants and risk of endometrial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.